NeuroOne Medical Technologies Corporation logo

NeuroOne Medical Technologies Corporation

NMTC | NASDAQ
Chart Builder DCF Calculator
$1.38
+$0.08 (+6.15%)
At close: Sep 22, 2026, 4:00 PM ET
$1.39
+$0.01 (+0.72%)
After-hours: Sep 22, 2026, 7:43 PM ET

Market Data

Market Cap
$11.31M
Enterprise Value
$9.34M
Beta
0.64
Average Volume
46.22K
Shares Outstanding (Diluted)
8.74M
Shares Change YoY
7.88%
Institutional Ownership
23.26%
Exchange
NASDAQ
ISIN
US64130M3088

Price Performance

Price Change 1M
-36.0%
Price Change 3M
-61.2%
Price Change 6M
-71.9%
Price Change YTD
-74.6%
Price Change 1Y
-76.7%
Price Change 3Y
-77.2%
Price Change 5Y
-94.8%
1M CAGR (ann.)
-20.3%
1Y CAGR (ann.)
-75.9%
5Y CAGR (ann.)
-46.0%
All-Time CAGR
-37.6%

Valuation

PE Ratio
-1.35
Forward PE
N/A
PEG Ratio
0.01
Forward PEG
0.10
PS Ratio
1.13
Forward PS
0.80
PB Ratio
3.00
P/FCF Ratio
-1.58
P/Adj. FCF Ratio
-1.32
P/OCF Ratio
-1.60
EV/Sales
0.93
EV/EBIT
-1.17
EV/EBITDA
-1.20
EV/FCF
-1.30
Earnings Yield
-73.8%
FCF Yield
-63.3%
Adj. FCF Yield
-75.8%

Financial Health

Net Cash
$2.05M
Total Debt
$73.32K
Cash & Short-Term Investments
$2.05M
Total Assets
$6.19M
Current Ratio
2.84
Quick Ratio
1.71
Debt / Equity Ratio
0.02
Debt / EBITDA
-0.01
Debt / FCF
-0.01
OCF / Debt
-96.18
Interest Coverage
22.76
Altman Z-Score
-18.22
Piotroski F-Score
2

Margins & Profitability

Gross Profit Margin
55.7%
Operating Profit Margin
-76.0%
EBITDA Margin
-69.1%
Net Profit Margin
-71.5%
FCF Margin
-71.6%
Adj. FCF Margin
-85.8%
SBC / Revenue
14.1%
SBC Impact (per share)
-19.7%

Returns

Return on Assets
-115.6%
Return on Equity
-126.5%
Return on Invested Capital
-183.4%
Return on Capital Employed
-183.4%
Return on Tangible Assets
-116.1%

Historical Growth (CAGR)

Revenue CAGR 3Y
98.4%
Revenue CAGR 5Y
37.2%
Revenue CAGR 10Y
173.2%
EPS CAGR 3Y
138.5%
EPS CAGR 5Y
61.3%
EPS CAGR 10Y
23.4%
FCF CAGR 3Y
28.0%
FCF CAGR 5Y
14.7%
FCF CAGR 10Y
-11.0%

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
4
EPS Growth Next 3Y
46.5%
Revenue Growth Next 3Y
42.1%
Earnings Date
Dec 14, 2026
EPS Estimate (next Q)
-$0.22
EPS Growth Est (next Q)
-27.8%
Revenue Est (next Q)
$2.79M
Revenue Growth Est (next Q)
2.8%

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$5
Price Target Upside
284.6%

Cash Flow

Operating Cash Flow
$-7.05M
Free Cash Flow
$-7.16M
Adj. Free Cash Flow
$-8.57M
FCF Per Share
-$0.83
OCF Per Share
-$0.81
OCF/S Ratio
-70.5%

Income Statement

Revenue
$10M
Gross Profit
$5.57M
Operating Income
$-7.6M
EBITDA
$-7.8M
Net Income
$-7.15M
EPS (Diluted)
-$0.96
Revenue / Employee
$555.44K
Profit / Employee
$-397.17K
Employees
18

© 2026 bestshares.com. All rights reserved.